Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Cantrell

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|May 1, 1974
Modification by passive IgM of the immune response of mice to a tumor allograftJ L Cantrell, N Kaliss
Transplantation|December 1, 1972
Characteristics of disparate histocompatibility barriers in congenic strains of mice. I. Graft-versus-host reactionsJ L Cantrell, W H Hildemann
Progress in Clinical and Biological Research|January 1, 1989
Role of novel adjuvants in specific active immunotherapyJ L Cantrell, D J Finn
Cancer Research|September 1, 1979
Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvumJ L Cantrell, R W Wheat
Transplantation Proceedings|March 1, 1973
Characteristics of histocompatibility barriers in congenic miceJ L Cantrell, W H Hildemann
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1973
Characteristics of disparate histocompatibility barriers in congenic strains of mice. II. Antibody-associated suppressionJ L Cantrell, W H Hildemann
Infection and Immunity|March 1, 1982
Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder miceJ C Williams, J L Cantrell
Cancer Research|July 1, 1981
Isolation of a nontoxic lipid A fraction containing tumor regression activityK Takayama, E Ribi, J L Cantrell
Journal of Biochemistry|May 1, 1983
Structural requirements of endotoxic glycolipid for antitumor and toxic activityK Amano, E Ribi, J L Cantrell
Biochemical and Biophysical Research Communications|June 15, 1982
Different structural requirements of endotoxic glycolipid for tumor regression and endotoxic activityK Amano, E Ribi, J L Cantrell
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|May 1, 1974
Modification by passive IgM of the immune response of mice to a tumor allograftJ L Cantrell, N Kaliss
Transplantation|December 1, 1972
Characteristics of disparate histocompatibility barriers in congenic strains of mice. I. Graft-versus-host reactionsJ L Cantrell, W H Hildemann
Progress in Clinical and Biological Research|January 1, 1989
Role of novel adjuvants in specific active immunotherapyJ L Cantrell, D J Finn
Cancer Research|September 1, 1979
Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvumJ L Cantrell, R W Wheat
Transplantation Proceedings|March 1, 1973
Characteristics of histocompatibility barriers in congenic miceJ L Cantrell, W H Hildemann
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1973
Characteristics of disparate histocompatibility barriers in congenic strains of mice. II. Antibody-associated suppressionJ L Cantrell, W H Hildemann
Infection and Immunity|March 1, 1982
Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder miceJ C Williams, J L Cantrell
Cancer Research|July 1, 1981
Isolation of a nontoxic lipid A fraction containing tumor regression activityK Takayama, E Ribi, J L Cantrell
Journal of Biochemistry|May 1, 1983
Structural requirements of endotoxic glycolipid for antitumor and toxic activityK Amano, E Ribi, J L Cantrell
Biochemical and Biophysical Research Communications|June 15, 1982
Different structural requirements of endotoxic glycolipid for tumor regression and endotoxic activityK Amano, E Ribi, J L Cantrell
Pageof 4